Cargando…

GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma

Immunotherapy based on immune checkpoint inhibitors (ICIs) is considered to be a promising treatment for stomach adenocarcinoma (STAD), but only a minority of patients benefit from it. It is believed that the poor therapeutic efficacy is attributed to the complex tumor immune microenvironment (TIM)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Lin, Chen, Shuming, Liu, Jianyong, Li, He, Zhao, Hu, Zheng, Chunhua, Zhang, Yawei, Huang, Hancong, Huang, Junjie, Wang, Bing, Lin, Chengzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132901/ https://www.ncbi.nlm.nih.gov/pubmed/37124060 http://dx.doi.org/10.1155/2023/7123568

Ejemplares similares

The circadian clock is associated with prognosis and immune infiltration in stomach adenocarcinoma
por: Huang, Zhihao, et al.
Publicado: (2021)

Exploring the Correlation Between GPR176, a Potential Target Gene of Gastric Cancer, and Immune Cell Infiltration
por: Gu, Xianhua, et al.
Publicado: (2023)

High expression of GPR176 predicts poor prognosis of gastric cancer patients and promotes the proliferation, migration, and invasion of gastric cancer cells
por: Zhang, Yu, et al.
Publicado: (2023)

CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma
por: Zhang, Jingxin, et al.
Publicado: (2022)

Evaluation of vital genes correlated with CD8 + T cell infiltration as prognostic biomarkers in stomach adenocarcinoma
por: Pan, Dun, et al.
Publicado: (2023)

IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma
por: Guo, Lili, et al.
Publicado: (2021)

Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma
por: Guo, Lili, et al.
Publicado: (2022)

The promoting effects of GPR176 expression on proliferation, chemoresistance, lipogenesis and invasion of oesophageal cancer
por: Yun, Wen-jing, et al.
Publicado: (2023)

LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022)

A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma
por: Khan, Muhammad, et al.
Publicado: (2022)

Increased SEC23A Expression Correlates with Poor Prognosis and Immune Infiltration in Stomach Adenocarcinoma †
por: Zhaoran, Su, et al.
Publicado: (2023)

High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma
por: Yan, Yanhua, et al.
Publicado: (2021)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma
por: Meng, Lingkai, et al.
Publicado: (2020)

Identification and functional characterisation of N-linked glycosylation of the orphan G protein-coupled receptor Gpr176
por: Wang, Tianyu, et al.
Publicado: (2020)

GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma
por: Huang, Yong, et al.
Publicado: (2022)

Integrative analysis reveals a clinicogenomic landscape associated with liver metastasis and poor prognosis in hepatoid adenocarcinoma of the stomach
por: Jiang, Junjie, et al.
Publicado: (2022)

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma
por: Shao, Changming, et al.
Publicado: (2021)

VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma
por: Zhang, Lihua, et al.
Publicado: (2020)

DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis
por: Lu, Yi, et al.
Publicado: (2022)

Gpr176 is a Gz-linked orphan G-protein-coupled receptor that sets the pace of circadian behaviour
por: Doi, Masao, et al.
Publicado: (2016)

GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer
por: Tang, Junwei, et al.
Publicado: (2023)

Constructing and Validating a Pyroptosis-Related Genes Prognostic Signature for Stomach Adenocarcinoma and Immune Infiltration: Potential Biomarkers for Predicting the Overall Survival
por: Xu, Jingmin, et al.
Publicado: (2022)

Immune Infiltration and Clinical Outcome of Super-Enhancer-Associated lncRNAs in Stomach Adenocarcinoma
por: Peng, Li, et al.
Publicado: (2022)

Identification of miRNA biomarkers for stomach adenocarcinoma
por: Qian, Hao, et al.
Publicado: (2022)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
por: Li, Hui, et al.
Publicado: (2023)

Oncogenic roles of GPR176 in breast cancer: a potential marker of aggressiveness and a potential target of gene therapy
por: Yun, Wen-jing, et al.
Publicado: (2023)

A Potential Diagnostic and Prognostic Biomarker TMEM176B and Its Relationship With Immune Infiltration in Skin Cutaneous Melanoma
por: Jiang, Linlan, et al.
Publicado: (2022)

Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma
por: Zhai, Yiyan, et al.
Publicado: (2023)

Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma
por: Huang, Zigao, et al.
Publicado: (2023)

GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma
por: Peng, Yunsong, et al.
Publicado: (2022)

Development a m(6)A regulators characterized by the immune cell infiltration in stomach adenocarcinoma for predicting the prognosis and immunotherapy response
por: Shi, Guodong, et al.
Publicado: (2023)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma
por: Guo, Ya, et al.
Publicado: (2020)

Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling
por: Liu, Chunhua, et al.
Publicado: (2022)

Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomach
por: Kang, Muxing, et al.
Publicado: (2022)

Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma
por: Zhu, Dandan, et al.
Publicado: (2022)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
por: Li, Lin, et al.
Publicado: (2023)

High Expression of the Component 3a Receptor 1 (C3AR1) Gene in Stomach Adenocarcinomas Infers a Poor Prognosis and High Immune-Infiltration Levels
por: Yang, Haibo, et al.
Publicado: (2021)

Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma
por: Zhou, Fang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_86el37vn6tarojgh1m54542n0c